Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 10, 2026

Shotgun Lipidomics of Rodent Tissues
11:46

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

2.7K

IntegraGen SA.

David Brady, Jan Mous1

  • 1IntegraGen SA , 4, rue Pierre Fontaine, 91000 Evry, France Tel; Fax; E-mail: bd@integragen.com ; www.integragen.com.

Personalized Medicine
|May 26, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Video-rate gigapixel ptychography via space-time neural field representations.

Nature communications·2026
Same author

Multiscale aperture synthesis imager.

Nature communications·2025
Same author

Design and implementation of a snapshot ptychographic wavefront camera array.

Optics express·2025
Same author

The Mediating Role of Intergenerational Stratification in the Long Arm of Childhood Income.

Demography·2025
Same author

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity.

International journal of molecular sciences·2024
Same author

Ptychographic wavefront cameras.

Optics letters·2024
Same journal

Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges.

Personalized medicine·2026
Same journal

Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.

Personalized medicine·2026
Same journal

Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.

Personalized medicine·2026
Same journal

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.

Personalized medicine·2026
Same journal

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Personalized medicine·2026
Same journal

Association between microRNA 155 gene polymorphism and sporadic Parkinson's disease.

Personalized medicine·2026
See all related articles

IntegraGen SA is commercializing innovative gene-mapping tests for predictive medicine. These IntegraTests™ offer personalized disease risk prediction, diagnosis, and treatment strategies for complex conditions.

Area of Science:

  • Genetics
  • Personalized Medicine
  • Diagnostics

Background:

  • The field of predictive medicine is rapidly expanding.
  • IntegraGen SA has developed proprietary gene-mapping technology.
  • Novel genetic markers are crucial for understanding complex diseases.

Purpose of the Study:

  • To commercialize innovative diagnostic tests for predictive medicine.
  • To establish a leadership position in the personalized medicine market.
  • To leverage gene-mapping technology for disease diagnostics.

Main Methods:

  • Application of proprietary GenomeHIP™ (Genome Hybrid Identity Profiling) gene-mapping technology.
  • Utilizing premier patient collections for genetic marker discovery.
  • Development of IntegraTests™ for personalized diagnostics.
Keywords:
complex diseasesdisease geneticsdisease-associated genesgenetic markersmolecular diagnosticspersonalized healthcarepharmacogeneticspredictive medicine

More Related Videos

Production and Characterization of Vacuum Deposited Organic Light Emitting Diodes
07:44

Production and Characterization of Vacuum Deposited Organic Light Emitting Diodes

Published on: November 16, 2018

9.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K

Related Experiment Videos

Last Updated: Feb 10, 2026

Shotgun Lipidomics of Rodent Tissues
11:46

Shotgun Lipidomics of Rodent Tissues

Published on: November 18, 2022

2.7K
Production and Characterization of Vacuum Deposited Organic Light Emitting Diodes
07:44

Production and Characterization of Vacuum Deposited Organic Light Emitting Diodes

Published on: November 16, 2018

9.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K

Main Results:

  • Discovery of novel genes and genetic markers associated with complex, multifactorial diseases.
  • Development of IntegraTests™ as a new class of personalized medicine diagnostics.
  • Identification of markers for metabolic syndrome and neuropsychiatric disorders.

Conclusions:

  • IntegraTests™ provide prediction, prevention, diagnosis, and tailored treatment for complex diseases.
  • These tests enable calculation of personal disease risk and identification of comorbidities.
  • Focus on metabolic syndrome and neuropsychiatric disorders with planned European launch in 2005.